TY  - GEN
AU  - Seino,Y
AU  - Min,K W
AU  - Niemoeller,E
AU  - Takami,A
TI  - Randomized, double-blind, placebo-controlled trial of the once-daily GLP-1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently controlled on basal insulin with or without a sulfonylurea (GetGoal-L-Asia)
SN  - 1463-1326
PY  - 2013///0418
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Asian People
KW  - Blood Glucose
KW  - Body Mass Index
KW  - Diabetes Mellitus, Type 2
KW  - blood
KW  - Dose-Response Relationship, Drug
KW  - Double-Blind Method
KW  - Drug Administration Schedule
KW  - Drug Therapy, Combination
KW  - Female
KW  - Glucagon-Like Peptide-1 Receptor
KW  - Glycated Hemoglobin
KW  - metabolism
KW  - Humans
KW  - Hypoglycemia
KW  - Hypoglycemic Agents
KW  - administration & dosage
KW  - Insulin
KW  - Japan
KW  - epidemiology
KW  - Male
KW  - Middle Aged
KW  - Peptides
KW  - Philippines
KW  - Postprandial Period
KW  - Receptors, Glucagon
KW  - antagonists & inhibitors
KW  - Republic of Korea
KW  - Sulfonylurea Compounds
KW  - Taiwan
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/j.1463-1326.2012.01618.x
ER  -